GRIP Molecular Technologies
GRIP Molecular Technologies is a Minnesota-based molecular diagnostics company focused on developing innovative electronic biosensor technology that enables rapid, lab-quality diagnostics at home. Founded in late 2019, the company aims to provide accessible and accurate medical testing solutions, transforming the landscape of at-home medical diagnostics through its patented graphene biosensors.
GRIP Molecular Technologies
University Enterprise Labs 1000 Westgate Drive Suite 122 Saint Paul, MN 55114
What We Do
GRIP's patented electronic biosensor technology provides rapid, convenient, and highly accurate testing solutions for multiple diseases using self-collected samples. The results are displayed on a standard smartphone and can be transmitted to healthcare providers for telehealth interactions.
Infectious Diseases
Key People
Edward Gillan
CEO | Chief Commercial Officer
Michael Osterholm
Clinical Advisor
Richard Minicus
Chief Financial Officer
Laurie Knutson
Vice President of Marketing
News & Updates
GRIP and MTL announced a successful clinical feasibility study of an electronic biosensor technology aimed at providing lab-quality diagnostics at home.
GRIP Medical Diagnostics biosensor technology has the potential to alter how diseases are detected, diagnosed, monitored, and treated.
Innovative graphene biosensors to facilitate home-based infectious disease testing.
Recognized for the potential of its technology to revolutionize healthcare and improve patient outcomes.